Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

RPGRIP1L Gene Joubert Syndrome Type 7 Genetic Test in UAE | 2,800 AED | DHA Licensed Facility

Executive Summary & Core Metrics

Executive Clinical Summary: This UAE-based diagnostic panel leverages Next‑Generation Sequencing (NGS) to detect pathogenic variants in the RPGRIP1L gene causative of Joubert syndrome type 7—a rare ciliopathy with hallmark brain malformations and developmental delay. The test offers 99.9% diagnostic sensitivity under ISO 9001:2015‑accredited processing (Cert: INT/EGQ/2509DA/3139), enabling definitive molecular diagnosis for timely neurological intervention and family planning.

✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy (8 AM – 11 PM).
✓ Clinical Guidance: Telephonic Post‑Test result interpretation with a neurogenetic specialist.
✓ Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
✓ Sample Options: Whole Blood, Extracted DNA, or One‑Drop Blood on FTA Card.

Test Overview & Methodology

The RPGRIP1L Gene NGS Test is a comprehensive molecular diagnostic tool that screens the entire coding region of the RPGRIP1L gene for single‑nucleotide variants, small indels, and copy number changes associated with Joubert syndrome type 7 (JBTS7). It serves as a definitive confirmation assay for infants and children presenting with the molar tooth sign on neuroimaging, hypotonia, and oculomotor apraxia. Below, we compare our UAE‑optimised NGS platform with the most common alternative diagnostic approach.

Feature Our NGS Test (UAE) Standard Sanger Sequencing / Panel
Method Next‑Generation Sequencing (NGS) – full gene analysis Sanger sequencing of selected exons / limited gene panel
Diagnostic Sensitivity 99.9% 85–90% (may miss deep intronic or copy number variants)
Turnaround Time 3 to 4 Weeks 6–8 Weeks
Comprehensive CNV Detection Yes – integrated bioinformatics pipeline Often requires separate MLPA assay
Price (AED) 2,800 2,200–3,500 (variable, incomplete coverage)

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics licensed by the Dubai Health Authority, I emphasise that this NGS test provides a robust molecular confirmation for Joubert syndrome type 7, guiding multidisciplinary care and family counselling. A negative result, however, does not exclude all genetic disorders; clinical correlation with neuroimaging and specialist evaluation remains mandatory. Always involve a certified genetic counsellor when interpreting results.”

— Lina Osama Zaki Quteineh, DHA Registration ID: 9294403

Medication Safety Advisory

⚠️ Medication Safety Notice

Do not discontinue any prescribed medication (anti‑epileptics, respiratory support, etc.) without consulting your attending physician. This genetic test is for diagnostic clarification only and does not replace acute medical management.

🚨 Emergency Red Flags: If the patient experiences new‑onset seizures, sudden loss of consciousness, or severe respiratory difficulty, do not wait for test results—seek immediate emergency medical attention.

Exclusion Criteria

This test is inappropriate for individuals who have received a whole‑blood transfusion or allogeneic bone marrow transplant within the last 6 weeks (donor DNA may interfere). For patients on chronic immunosuppression, please discuss with our laboratory.

Patient FAQ & Clinical Guidance

1. What exactly does the RPGRIP1L gene test detect, and who should consider it?

Our NGS test identifies pathogenic variants across the entire RPGRIP1L gene that cause Joubert syndrome type 7, a rare neurological ciliopathy. It is clinically indicated for infants and young children presenting with cerebellar vermis hypoplasia (molar tooth sign), hypotonia, abnormal eye movements, and developmental delay. A paediatric neurologist or clinical geneticist typically orders the test following abnormal cranial MRI findings.

2. How accurate is this test, and can it predict the severity of Joubert syndrome?

With a diagnostic sensitivity of 99.9% using ISO‑accredited NGS technology, this assay reliably detects single nucleotide variants, indels, and copy number changes. However, genotype‑phenotype correlation in Joubert syndrome is complex; the same gene mutation can lead to a wide spectrum of clinical severity. The report interprets pathogenicity based on ACMG guidelines and provides a risk assessment for family members, but it cannot precisely forecast individual motor or cognitive outcomes.

3. What type of sample is needed, and how long will it take to get my results?

A simple blood draw (3 mL in EDTA tube), extracted DNA, or a single drop of blood on a specially designed FTA card is sufficient for this analysis. Our trained mobile phlebotomist will arrive at your home or clinic in a cold‑chain‑equipped vehicle. Once the sample reaches our accredited laboratory, the final genetic report is released within 3 to 4 weeks. A telephonic interpretation session with a clinical genetics counsellor is included at no extra cost.

UAE Regulatory & Data Privacy Adherence

Legal Compliance Framework

  • Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL)
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
  • Federal Decree‑Law No. 4 of 2016 on Medical Liability
  • ISO 9001:2015 Certified Facility (Certificate: INT/EGQ/2509DA/3139)

Our laboratory operates under DHA Facility License 1143, ensuring adherence to the highest quality and safety standards for genetic diagnostics in the Emirates. Physical address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE.

Clinical & Logistical Metadata

Test Name RPGRIP1L Gene Joubert Syndrome Type 7 Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks
Sample Type / Matrix Whole Blood (EDTA), Extracted DNA, or FTA Card
Methodology Used Next‑Generation Sequencing (NGS)
ICD-10-CM Code Q04.3
LOINC Code 81247-9
DHA Facility License & Laboratory Address License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians